Alternatives to ImmunoBrain Checkpoint

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Developing novel diagnostics to predict patient response to immunotherapy.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Arbiter uses voice analytics to detect patient health changes and predict risks for care teams.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.